Jiangxi Huieren Pharmaceutical

Jiangxi Huieren Pharmaceutical is a leading Chinese pharmaceutical enterprise primarily focused on the Traditional Chinese Medicine (TCM) sector. Established in 1992 and based in Nanchang, the company has built a strong brand reputation through its flagship product, Shenbao Tablets, which is a market leader in the kidney-tonifying segment in China. Huieren integrates R&D, manufacturing, and sales, operating high-standard GMP production lines for various dosage forms including tablets, capsules, and oral liquids. Their product portfolio addresses a wide range of health concerns, including respiratory issues, digestive health, and gynecological conditions. The company is recognized as a Key High-tech Enterprise in China and continues to modernize traditional herbal formulations for the contemporary healthcare market.